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Retinoids have been shown to modulate the expression of 
proteins involved in epidermal differentiation. To examine 
this effect in an in vitro skin model, we evaluated the effect of 
retinoic acid on the expression of two cell envelope proteins, 
loricrin and involucrin, and an early marker of epidermal 
differentiation, keratin 1, in a reconstituted human skin 
equivalent cultured at the liquid-air interface. Retinoic acid, a 
known inhibitor of keratinization in monolayer and raft cul-
tures, was evaluated for its ability to alter the expression and 
distribution of these markers of epidermal differentiation. 
Retinoic acid (10- 6 M) suppressed loricrin expression in skin 
T he corneocyte envelope is a chemically resistant struc-ture located beneath the plasma membrane, which is formed by the crosslinking of protein precursors as-sembled in terminally differentiated epidermal kerati-nocytes [1- 3]. A number of proteins have been shown 
to be incorporated in the envelope [4 - 9 j; however, attention has 
centered on two of these precursors, loricrin [8 -11] and involucrin 
[1,12-15]. Whereas both participate in the assembly of the com-
plete envelope, they are differentially expressed. Loricrin is ex-
pressed at later stages of ill vivo differentiation than is involucrin, as 
seen by its less extensive distribution and restriction to the upper 
epidermis (compare [8 ,9] with [14 ,15]). Involucrin is expressed in 
submerged cultures grown on plastic in both low- and high-calcium 
media [16] whereas loricrin is expressed only in high-calcium media 
[10,11]. With the addition of retinoids, loricrin expression is sup-
pressed [10], whereas involucrin is not [15 ,17]. 
The culture of epidermal keratinocytes on fibroblast-contracted 
collagen gels at the liquid-air interface [18 - 21) provides the oppor-
tunity to study the mechanisms by which the expression of these 
two proteins is regulated in a system where cell interactions more 
closely resemble that of the developing epidermis. Therefore, in the 
present study we analyzed the expression of these cell envelope 
proteins in this three-dimensional culture system, and examined the 
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cultures as determined by both protein and mRNA analysis. 
In contrast, no inhibition of involucrin or K 1 expression was 
observed at the protein level at the same retinoic acid concen-
tration. However, some suppression ofK1 mRNA transcrip-
tion was observed in retinoic acid-treated cultures. These 
results demonstrate that in differentiating cultures of recon-
stituted human skin, loricrin expression is markedly inhib-
ited by retinoids, K1 less so, and involucrin not at all. 
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effects of retinoids on the synthesis of these and other markers of 
epidermal differentiation. 
MATERIALS AND METHODS 
Keratinocyte Cultures Human keratinocytes were isolated from fore-
skin following an overnight incubation in 1% trypsin in versene (Sigma 
Chemical, St. Louis, MO). The cells were placed on feeder layers of 
mitomycin-C-treated Swiss 3T3 (American Type Culture Collection, 
Rockville, MD) fibroblasts. The cultures were maintained in an epidermal 
growth media (E-media) containing the high-glucose form of Dulbecco's 
Modified Eagle Media (DMEM) supplemented 3: 1 with Ham's F-12 Nu-
trient Mixture (Gibco, Grand Island, NY), 5 X 10- 10 M cholera toxin 
(Schwarz-Mann Biotech), 2l1g/ml hydrocortisone, 2511g/ml insulin, 
25,ug/ml transferrin (Sigma), and 1 X 10- 10 M triiodothyronine (19]. 
Construction of the Skin Equivalent (SE) Skin equivalents were pre-
pared uSlllg a variation of a technique established by Bell and coworkers 
[20,21] and modified by Kopan et al [1 9]. Briefly, normal human neonatal 
dermal fibroblasts at 3.3-4.7 X 10' cells/ml in 3 ml DMEM with 10% calf 
serum were mixed with 1 ml of2.5 mg/ml rat tail collagen (Collaborative 
Research, Bedford, MA). The mixture was allowed to gel and contract in a 
sterile 35-mm petri dish [20] . After approximately 5 d, keratinocytes were 
added to the surface of the dermal equivalent. The resulting SEs were grown 
at 37°C and 7% CO2 [19,21], submerged in E-media. Cultures remained 
submerged for approximately 1 week to allow for epidermal attachment and 
monolayer formation. At this time they were placed on a steel mesh grid at 
the liquid-air interface. From this point, untreated cultures were fed every 
other day with E-media, while treated cultures were fed on the same sched-
ule with varying concentrations of all-trans retinoic acid (Sigma), which was 
dissolved in ethanol, in the media [19]. The final concentrations of ethanol 
in all cultures was 1 %. Solutions were prepared and dosing was performed 
under yellow-light conditions. Retinoic acid (RA) was then refrigerated and 
stored under nitrogen in foil-covered amber bottles to protect from the light. 
The equivalents wete harvested on day 10 of treatment and frozen in liquid 
nitrogen. 
Immunohistochemical Localization Tissues were embedded in Histo 
Prep embedding compound (Fisher, Springfield, NJ). Four-micron sections 
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of both skin equivalents and foreskin were cut on a Minotome cryostat, 
mounted on gelatin-coated slides, air dried, and subsequently fixed in ace-
cone (- 20°C) for 5 min. Sections were stained by standard indirect immu-
nochemical techniques [22] . Control sections were incubated with the ap-
propriate nonimmune antiserum and non~specific s~aining was not observed. 
The primary antisera used were rab~lt anti-human mvolu~nn (a total of four 
antibodies were tested, one from BIOmedical Technologies Inc. [BTl], two 
graciously provided by Dr. Marcia Simon [23]. and one provided by Dr. Scott 
Thatcher [24]; only the BTl results are shown), rabbit or guinea pig anti-llU-
man keratin 1 (Kl) [25], and rabbit anti-loricrin [8]. 
Sections visualized by immunofluorescence were hydrated in phosphate-
buffered saline followed by sequential incubation in 12% bovine serum 
albumin in 0.01 M Tris-buffered saline, normal blocking serum, primary 
antibody, and finally, the fluorescein-conjugated secondary antibody (Sigma 
or Dako-Patts). For immunoenzyme staining, the procedure was similar 
except the last incubation is replaced by a sequential incubation in biotiny-
lated secondary antibody (Vector, Burlingame, CA or BTl; not shown) 
followed by the avidin-biotin-peroxidase complex (Vector or BTl; not 
shown). Antibody binding was then visualized using 3,3' -diaminobenzidine 
(Sig=a). The sections were then counterstained in hematoxylin (Sigma) and 
mounted. All incubations were done in a humidity chamber. 
RNA Isolation Total RNA was extracted from the skin equivalents (two 
per RA concentration) with RNAzol B (Biotecx Laboratories, Inc., Hous-
con, TX) based on a previously described method [26]. The RNA was repre-
cipitated in the presence of 0.2 M NaCI with 2 vol of ethanol for 1 h at 
-20°C, then washed twice with 75% ethanol and resuspended in 40 III of 
1 roM ethylenediamine tetraacetate in diethylpyrocarbonate-treated water 
and stored at -70°C. 
cDNA Synthesis Five micrograms of total RNA in 8 III of water was 
heated to 65°C for 5 min, chilled on ice, and then added to a master mix 
containing 2 III 10 X reverse transcriptase buffer (1 X RT) buffer is 50 mM 
Tris-HCl, pH 8.15, at 41°C; 40 mM KCl, 6 mM MgCl2 , 10 mM dithio-
threitol, and 20 U of RNa sin (Promega, Madison, WI), 2 III of each 10 mM 
deoxynucleotide triphosphate (dNTP) and 1 Jil of 10 Jig/Jil random hex-
amer primers [pd(N)6' Pharmacia, LKB Biotechnology, Inc., Piscataway, 
NJ]. One microliter of 20 units/ Jil avian myeloblastosis virus reverse tran-
scriptase (Life Sciences, St. Petersburg, FL) was added to give a final volume 
of20 ,111 was incubated at 41 'C for 90 min. The resultant eDNA was diluted 
1 in 50 with water and stored at - 20°C. 
polYDlerase Chain Reaction (PCR) Amplification Oligonucleotides 
for PCR were designed to yield a product size of the order 100 - 400 base pair 
(bp) and to span an intron to safeguard against the possibility of spurious 
amplification of contaminating genomic DNAs. The sequences of the 5' and 
3' oligonucleotides are shown for their respective mRNA species, as follows: 
for human keratin 14, 5'-TTCTCACAGCCACAGTGGAC-3' and 
5'_CATTGACATCTCCACCCACC-3'; for human involucrin, 5'-
TGCCTCAGCCTTACTGTGAG-3' and 5'-GCAGTCCCTTTACAG-
CAGTC-3'; for human loricrin, 5'-TCACTCACCCTTCCTGGTGC-3' 
and 5'_CACCGCCGCCAGAGGTCTTC-3'; and for human keratin 1, 
5' -A TAGCCCAGAAGAGCAAAGC-3' and 5' -TCGGGGCACATTCT-
CCAGAC-3'. Based on the published eDNA sequences, these primers were 
expected to generate fragments of 281 bp for keratin 14 [27J , 251 bp for 
involucrin [28],116 bp for loricrin [9], and 418 bp for keratin 1 [29]. 
The PCR reaction of 100 III consisted of 10 III 10 X PCR Buffer (Perkin 
Elmer Cetus, Norwalk, CT), 2 III each 10 mM dNTP, 1 III diluted eDNA, 
1 III of 5' primer at 200 ng/IlI, and 1 III of 3' primer at 200 ng/IlI, 78 III 
H20, and 1 III (5 unitS/ill) of Tilermlls aqllaticus (Taq) DNA polymerase (Perkin Elmer Cetus). Reactions were performed in a DNA thermal cycler 
according to the manufacturer's instructions. Samples were heated to 95°C 
for 5 min, then cooled to 50'C for 2-min annealing and the second strand 
extended at 72°C for 10 min. Subsequently, 30 cycles of amplification were 
carried out using a step program (denaturation, 95 °C for 30 sec, annealing, 
60°C for 1 min, and extension, 72°C for 1 min). The final extension was at 
noc for 15 min. 
RESULTS 
Histology The SE (Fig 1A) exhibited a similar morphology 
when compared to normal human foreskin. Clearly distinguishable 
stratified epidermal cell layers were formed in the SE, including a 
stratum basalis, spinosum, granulosum, and corneum-like layers. 
Differences between the two systems are also evident. Specifically, 
the model has a parakeratotic stratum corneum and lacks dermal 
papillae, vasculature, and nerves. 
SE cultures treated with RA at 10-7 and 10-6 M (Fig 1B,C) re-
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tained their keratinized morphology but exhibited a hyperplastic 
response that was most prominent at 10-6 M RA. The epidermis of 
cultures treated with RA showed a dose-dependent decrease in in-
tercellular adhesion resulting in less cell-to-cell contact, as has been 
reported previously [19] . The loss of intercellular adhesion was 
particularly marked at 10-6 M RA. Cultures grown in the presence 
of 10-5 M RA did not develop a keratinizing epidermis (data not 
shown), but instead varied in thickness from multiple cell layers to a 
single very darkly stained layer that appeared necrotic. Due to the 
apparent toxicity of 10- 5 M RA on the SE cultures, only nontoxic 
doses (:5 10-6 M) were used for comparisons of differentiation 
markers. 
Immuuolocalization Loricrin is a major component of the ke-
ratinocyte cell envelope and is expressed late in epidermal differen-
tiation [8] . In the untreated skin equivalent (Fig lA) staining was 
restricted to the epidermis, specifically from the upper stratum spin-
osum to the stratum corneum. This localization is comparable to 
that seen in human epidermis ill I!iVO [9]' Loricrin was still detectable 
at 10-7 M RA (Fig lB); however, the staining intensity was mark-
edly reduced at 10-6 M RA (Fig le). A similar but less intense 
pat~ern of expression was obtained when using an antibody directed 
agalllst the N -terminal portion of loricrin (DR Roop, unpublished 
data) (data not shown). The basis for the staining of the epidermal 
nucl~i in the skin equivalent is not known; however, it appears to be 
SP~CI?C to ~he C-terminal antibody because it was not present when 
stallllllg With the N-terminal-directed antibody. 
Involucrin is a corneocyte envelope protein that is expressed early 
in epidermal differentiation [1]. In untreated SE cultures (Fig 1D), 
involucrin staining was seen throughout the suprabasallayers of the 
epidermis, with gradually increasing intensity approaching the stra-
tum corneum. Unlike ill vivo epidermis, involucrin staining was 
distributed heterogeneously throughout the cytoplasm rather than 
at the cell periphery. This pattern was specific to the SE because 
for~sklI1. s~lOwed staining at the cell periphery (data not shown). 
ThiS sta~nlI1g was observed regardless of whether immunoperoxi-
dase or Immunofluorescence methods of detection were used and 
occurred with all involucrin antibodies listed in the Materials and 
Methods section. Skin equivalent cultures reach a proliferative rate in 
~he range of normal skin after approximately 16 d at the liquid-air 
lllterface. Cytoplasmic staining of involucrin may be attributed to 
the hy~erproliferative state of our short-term cultures (10 d) ofSEs, 
~here It could ~e speculated that a change towards peripheral stain-
lI1g may occur III cultures grown longer at the liquid-air interface 
([30,31], NL Parenteau personal communication). Involucrin (Fig 
1F) could be detected by antibodies at a RA concentration of 
10-6 M, in contrast to loricrin, which was inhibited at this concen-
tration. The addition of RA produced no change in the distribution 
of involucrin (Fig IF) and similar results were obtained regardless of 
the involucrin antibody used (data not shown). 
Keratin 1, an early marker of differentiating epidermal cells, was 
expressed suprabasally in untreated SE (Fig 1C) cultures. K1 stain-
ing was also evident at all doses of RA treatment; however the 
distribution appeared to be restricted to the uppermost layers of the 
SEs (Fig 1H,I). 
RNA Analysis The relative abundance of RNA transcripts for 
Kl., K14, involucrin, and loricrin was determined by reverse tran-
scnptase/PCR [32] . Loricrin mRNA was undetectable at RA con-
ce~trations of 10-5 and 10- 6 M (Fig 2). Some suppression of lori-
cnn mRNA transcription was also evident at a RA concentration of 
10-7 M. Kl transcription appeared partially suppressed at RA con-
centrations of 10-5 and 10-6 M. In contrast, gene expression for 
both the basally expressed keratin K14 and suprabasally expressed 
involucrin were refractory to the presence ofRA. Thus an argument 
can be made that the RA effect is specific for a subset of keratinocyte 
genes and not a consequence of a global effect due to cell poisoning 
and/or tissue necrosis. The suppression of Kl [25,33] and loricrin 
[10] expression by RA has previously been observed in submerged 
cultures. 
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DISCUSSION 
Skin equivalent culture systems have the advantage over monolayer 
keratinocyte cultures in that they not only express all of the markers 
of the epidermis but also mimic the architecture of the epidermis. In 
the present study we demonstrate the expression of both early and 
late markers of differentiation in an SE model employing a con-
tracting dermal matrix. The expression of these markers in this 
system was similar to that of ill vivo epidermis with respect to both 
onset and localization. The early marker, K1, was detected 
throughout the suprabasallayers. Involucrin expression had a simi-
lar distribution in these cultures and preceded loricrin expression, 
which was restricted to the upper layers. 
Having established the expression of these markers in our SE 
model, we tested the effect of RA on their expression in this model. 
Interestingly, the expression of the two envelope proteins was dif-
ferentially affected by RA in these SEs. Involucrin expression (Fig 
1F) was not inhibited at retinoid concentrations shown to inhibit 
the expression of loricrin (Fig 1 C) in developing SEs. The lack of 
loricrin expression was not due to a masking of the C-terminal 
loricrin epitope in response to RA because inhibition was also seen 
with an antibody to the N-terminal region (data not shown) . More-
over, mRNA analysis demonstrated that loricrin transcripts were 
not present in cultures treated with 10-6 M RA. An apparent reduc-
tion in loricrin mRNA was already observed at a RA concentration 
of 10- 7 M, in contrast to involucrin transcripts, which were present 
in all RA concentrations tested. In comparison, SE cultures treated 
with 10- 6 M RA also exhibited a partial reduction in K1 mRNA 
levels and no reduction in mRNA levels for K14. Although PCR 
amplification is only semiquantitative, these data are consistent 
with the previous report on the expression of K14 and K1 at the 
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protein level [19] . Therefore, the separate regulation ofloricrin and 
involucrin in skin equivalents appears to occur at the mRNA level. 
In the course of these studies, similar results were published [34] 
showing loricrin suppression in skin cultures treated with RA. In 
addition to these findings, we have demonstrated in our model the 
expression of K1 in conjunction with a morphologically normal-
appearing epidermis (Fig lJ) at concentrations of RA that inllibit 
loricrin expression (Fig 1 C). In our hands at 10- 6 M RA, there is an 
apparent reduction, but not elimination, in the amounts of K1 
mRNA, which may explain the more restricted staining for K1 to 
the upper suprabasallayers. Complete inhibition of K1 expression 
by RA in SEs has been associated with loss of the keratinizing phe-
notype in several previous studies [18,19,34,35] . However, in our 
studies K1 is expressed at both the mRNA (Fig 2) and protein levels 
(Fig lJ) at 10- 6 M RA. The expression of K1 in our cultures at 
10-6 M RA may be associated with the presence of a keratinized 
phenotype at this concentration. This is consistent with the acute 
response of human epidermis irl vivo to topical RA treatment, where 
the keratinized phenotype was maintained, as was K1 expression, 
but with an inhibition of loricrin expression [36]. Differential ex-
pression of loricrin and 1<.1 has also been reported in response to 
phorbol ester treatment [37] and changes in calcium concentration 
in cultured mouse keratinocytes [11]. 
We have determined several differences in our culture condi-
tions, compared to those previously reported [19,34]' which could 
account for the difference in K1 sensitivity to RA at 10-6 M. Con-
sidering the substantial increase in added RA over the concentration 
of RA in serum, it is unlikely that variations in serum RA levels in 
these different studies could account for the differences observed in 
K1 expression. Because there are some differences in the media used 
in our study and that ofMagnaldo et af [34]. it is possible that certain 
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Figure 1. Immunolocalization of loricrin, involucrin, and K 1. The distri-
bution of the envelope proteins loricrin (A-C) and involucrin (D-F) and 
the keratin K1 (G-I) is shown for skin equivalents treated with 1 % ethanol 
(A,D,G), 10-7 M RA in 1 % ethanol (B,E,H), or 10-6 M RA in 1 % ethanol 
(C,F,I). The procedure for immunoenzyme (A - C) and immunofluorescent 
(D-I) techniques is described in the Materials alld Met/rods. Bar, 10.uM. 
media or serum components may influence retinoid regulation of 
epidermal differentiation. In addition, our dermal matrix employs 
human skin fibroblasts, which differs from the previous reports 
using immortalized mouse fibroblasts [19,34]. If the dermis is re-
sponsible for making the retinoid available to the epidermis, cell 
origin may be a factor in RA activity by effecting the bioavailability 
of the retinoid. Alternatively, fibroblasts with different origins may 
have the potential to differentially influence the expression of kera-
tinization markers in the epidermis of SEs [38]. 
The differential expression of the two envelope proteins loricrin 
and involucrin within the epidermis raises an interesting paradox 
c?ncerni~g c.orneocyte envelope assembly. Ski~ ~quivalents that 
differentiate 111 the presence of 10-6 M RA exhlbtt an apparently 
cornified epithelium in the absence ofloricrin, raising the possibil-
ity that cell envelopes are being formed without loricrin participa-
tion. Similar observations have been made in monolayer cultures 
that express involucrin [16] but not loricrin [10], yet will form an 
envelope-like structure [39]. However, these envelopes are less rigid 
than those formed ill vivo [39]. It remains to be determined whether 
envelopes are being formed in the SE system. If this can be demon-
strated, those formed in the presence or absence of RA may have 
different biophysical properties attributed to the absence ofloricrin. 
Thus, the SE would make an appropriate model for studying the 
contribution of loricrin to envelope structure and its properties. 
The results of this study further support the use of in vitro skin 
model cultures to analyze the effects of pharmacologic agents, such 
as retinoids, on human skin. Although these culture models are not 
identical replicas of the morphologic and biochemical status of nor-
mal skin, their use can provide significant insight into the molecular 
mechanisms that control epidermal differentiation. 
HK14 HI HL HK1 




Figure 2. RNA transcript levels for retinoic acid-treated skin equivalents. Analysis of transcription by PCR showing the relative abundance of RNA 
transcripts for keratin 1 (HK1), keratin 14 (HK14), involucrin (HI), and loricrin (HL) in untreated and RA treated skin equivalents. Five microliters of each 
peR sample (5% by volume) was electrophoresed on a 2% agarose gel and visualized with ethidium bromide. M, molecular size standards (Hae III digested 
cl>X174); c, control tissue/untreated skin equivalents; 10- 5 , skin equivalents treated with 10- 5 M RA; 10- 6 , treated with 10- 6 M RA; 10-7 , treated with 
10-7 M RA. To test for the possibility of amplification of processed pseudogenes from contaminating DNA, RNA samples were directly subjected to 30 cycles 
of peR using the K14-specific oligos and no products were detected (data not shown). 
890 BROWN ET AL 
This work was supported in part by NIH gra"t 5R01 AR40240-02 a"d a Focused 
Givillg grallt from joh"so" atld jollllson awarded to DRR. 
We wish to tha"k Dr. Raphael Kopall for his help with the skill equivale"t 
teciHliq lle, Dotulie Blltldman for Iler help with tire immll"ohistocilemistry, a"d Dr. 
Natley Parellteau for her helpful SIJggestiOIlS. 
REFERENCES 
I. Rice RH, Green H: The cornified envelope of terminally differentiated human 
epidermal keratinocytes consists of cross-linked protein. Cell 11:417-422, 
1977 
2. Matoltsy AG, Balsamo CA: A study of the components of cornified epithelium of 
human skin.] Biopllys Bioclrem Cytoll:339-360, 1955. . 
3. Sun T -T, Green H: Differenriation of the epidermal keratmocyte 10 cell culture, 
formation of the cornified envelope. Cell 9:511- 521, 1976 
4. Zettergel1 JG, Peterson LL, Wuepper KD: Keratolinin: d,e soluble substrate of 
epidermal transglutammase from human and bovme tISsue. Proc Natl Acad SCI 
USA 81:238-242, 1984 
5. Simon M, Green H: Participation of membrane-associated proteins in the forma-
tion of the cross-linked envelope of the keratinocyte. Cell 36:827 -834, 1984 
6. Ma S-P, Sun T-T: Differentiation-dependent changes in the solubility of a 195-kd 
protein in human epidermal keratinocytes.] Cell Bioi 103:41-48, 1986 . 
7. Kubilus J, Baden HP: Isolation of two immunologically related transglutammase 
substrates from cultured human keratinocytes. III Vitro 18:447 -455, 1982 
8. Mehrel T, Hohl D, Rothnagel J, Longley M, Bundman D, Cheng C, Lichti U, 
Bisher M, Steven A, Steinert P, Yuspa S, Roop D: Identification of a major 
keratinocyte cell envelope protein, Loricrin. Cell 61:1103-1112, 1990 . 
9. Hohl D, Mehrel T, Lichti U, Turner M, Roop D, Stemert P: Charactenzatlon of 
human loricrin.] Bioi Cllem 266:6626-6637, 1991 .. 
10. Hohl D, Lichti U, Breikreutz D, Steinert P, Roop D: Transcnptlon of the human 
loricrin gene in vitro is induced by calcium and cell density and suppressed by 
retinoic acid.] IIIV<5t DermatoI96:414-418, 1991 . . . 
II. Yuspa SH, Kilkenny AE, Steinert PM, Roop DR: ExpreSSIon of munne epidermal 
differentiation markers is tightly regulated by restricted extracellular calcIUm 
concentrations in vitro.] Cell Bioi 109:1207 -1217, 1989 
12. Rice RH, Green H: Presence in h~man epideqnal cells of a soluble ~recursor of the 
cross-linked envelope: activation of the crosshnkmg by calcIUm Ions. Cell 
18:681-694,1979 
13. Simon M, Green H: Enzymatic crosslinking of involucrin and other proteins by 
keratinocyte particulates in vitro. Cell 40:677 -683, ~985 . . 
14. Rice RH, Pinkus GS, Warhol MJ, Antonioki: Involucnn; biochemIStry and Im-
munochemistry. In: Sternberg S, DeLellis R (eds.). Advallw ill Imm,mollisto-
ellemistry. Mosby Yr Bk, St. Louis, MO, 1984, pp 111-125 . 
15. Banks-Schlegel S, Green H: Involucrin synthesis and tissue assembly by keratmo-
cytes in natural and cultured epithelia.] Cell Bioi 90:732-737, 1981 . 
16. Watt FM, Green H: Stratification and terminal differentiation of cultured epIder-
mal cells. Natllre (Lolldoll) 295:434 - 436, 1982 
17. Green H, Watt FM: Regulation by vitamin A of envelope cross-linking in cul-
tured keratinocytes derived from different human epithelia. Mol Cell Bioi 
2:1115-1 11 7,1982 
18. Regnier M, Darmon M: Human epidermis reconstructed in vitro: a model to study 
keratinocyte differentiation and its modulation by retinoic acid. III Vitro Cell 
Dev Bioi 25:1000-1008, 1989 
19. Kopan R, Traska G, FuchsE: Retinoids as important regulators of terminal differ-
entiation: examining keratin expression in individual epidermal cells at vanous 
stages of keratinization.] Cell Bioi 105:427-440, 1987 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
20. Bell E Ivarsson B Merril C: Production of a tissue-like structure by contraction of coll~gen l attic~s by human fibroblasts of different proliferative potential in 
vitro. Proe Natl Ae.d Sci USA 76:1274-1278, 1979 
21. Bell E Sher SHull B Merrill C, Rosen S, Chamson A, Asselineau D, Dubertret 
L, Coulomb B, Lapiere c, Nusgens B, Neveux Y: The reconstirution ofliving 
skin.] Ifl V<5t Dermato/81:2S - IO S, 1983 
22. Vandesande F: Peroxidase-antiperoxidase techniques. In: Cuello AC (ed.). Metlt-
ods ifl tire Nellroscieflces, Vol. 3. John Wiley & Sons, Chichester, PA 1983, pp 
101-120 
23. Simon M, Green H: Involucrin in the epidermal cells of subprimates.] [,,,,,,t 
Dermato/92:72I- 724, 1989 
24. Thatcher SM, Rice RH: Keratinocyte-specific transglutaminase of cultured 
human epidermal cells: relation to crosslinked envelope formation and ternunal 
differentiation. Cell 40:685-695, 1985 
25. Rosenthal DS, Steinert PM, Chung S, HuffCA,JohnsonJ, Yuspa SH, Roop DR: 
A human epidermal differentiation-specific keratin gene is regulated by cal-
cium but not negative modulators of differentiation in transgenic mouse keratl-
nocytes. Cell Growth D!lferellt 2:107 -113, 1991 .. 
26. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid gUallldl-
nium thiocyanate-phenol-chloroform extraction. Aflal Biochem 162:156-159, 
1987 
27. Marchuck D, McCrohon S, Fuchs E: Complete sequence of a gene encoding a 
human type I keratin: sequences homologous to enhancer elements in the 
regulatory region of the gene. Proe Na t! Aead Sci USA 82:1609-1613, 1985 
28. Eckert RL, Green H: Structure and evolution of the human involucrin gene. Cell 
46:583-589,1986 
29. Johnson LD, Idler WW, zhou X-M, Roop DR, Steinert PM: Structure of a gene 
for the human epidermal 67-kDa keratin. Proc Nat! Aead Sci USA 82:1896-
1900,1985 . 
30. Parenteau NL, Bilbo P, Nolte CJM, Mason VS, Rosenberg M: The organotyplc 
culture of human skin keratinocytes and fibroblasts to achieve form and func-
tion. Cytotech 9:163-171,1992 
31. Wilkins LM, Watson SR, Prosky SJ, Meunier SF, Parenteau NL: Development?f 
a bilayered living skin construct for clinical applications. Biotech Bioeng (111 
press). 
32. Kawasaka E, Wang AM: Detection of Gene Expression. In Erlich MA (ed.), PCR 
Tecllllology. Stockton Press, New York, 1989, pp 89-97 . 
33. Roop DR, Chung S, Cheng CK, Steinert PM, Yuspa SH, Rosenthal DS: Epider-
mal differentiation and its modulation by retinoids. In: Reichert U , Shroot B 
(cds.). Pharmacology ofRetifloids illtl .. Skill. Basel, Karger, 3:1-7, 1989 .. 
34. Magnaldo T, Bernard F, Asselineau D, Darmon M: Expression of 10ncnn .1S 
negatively controlled by retinoic acid in human epidermis reconstructed In 
vitro. D!f{erelltialioll 49:39-46,1992 
35. Assclineau D, Bernard B, Bailly C, Darmon M: Retinoic acid improves epidermal 
morphogenesis. Dev Bioi 133:322-335, 1989 . 
36. Rosenthal DS, Griffiths CEM, Yuspa SH, Roop DR, VorheesJJ: Acuteorchroruc 
topical retinoic acid treatment of human skin in vivo alters the expression of 
epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 
13 but not keratins I, 10, and I4.J r,We5I Dermato198:343-350, 1992 
37. Dlugosz AA, Yuspa SH: Coordinate changes in gene expression which mark the 
spinous to granular cell transition in epidermis are regulated by protein kinase 
C. ] Cell Bioi 120:217-225, 1993 
38. Wilson JL, Dollard SC, Chow LT, Broker TR: Epithelial-specific gene-expres-
sion during differentiation of stratified primary human keratinocyte cultures. 
Cell Growth D!f{emlt 3:471 - 483, 1992 . 
39. Michel S, Schmidt R, Shroot B, Riechert U: Morphological and biochemIcal 
characterization of cornified envelopes from epidermal keratinocytes of differ-
ent origin.] Iflvest Derlllatol91 :11 - 15, 1988 
